Adult and fetal haematopoietic stem cells (HSCs) display a glycolytic phenotype, which is required for maintenance of stemness; however, whether mitochondrial respiration is required to maintain HSC function is not known. Here we report that loss of the mitochondrial complex III subunit Rieske iron-sulfur protein (RISP) in fetal mouse HSCs allows them to proliferate but impairs their differentiation, resulting in anaemia and prenatal death. RISP-null fetal HSCs displayed impaired respiration resulting in a decreased NAD + /NADH ratio. RISP-null fetal HSCs and progenitors exhibited an increase in both DNA and histone methylation associated with increases in 2-hydroxyglutarate (2HG), a metabolite known to inhibit DNA and histone demethylases. RISP inactivation in adult HSCs also impaired respiration resulting in loss of quiescence concomitant with severe pancytopenia and lethality. Thus, respiration is dispensable for adult or fetal HSC proliferation, but essential for fetal HSC differentiation and maintenance of adult HSC quiescence.
Haematopoietic stem cells (HSCs) require tight regulation of cell cycle, apoptosis and oxidative stress to sustain a balance between HSC quiescence, self-renewal and differentiation. Deregulation of this balance can result in the development of blood disorders such as anaemia and leukaemia. Emerging evidence suggests that the metabolic state of HSCs regulates haematopoiesis, although the mechanisms that link metabolism to HSC function remain poorly understood 1, 2 . Many of the metabolic studies on haematopoiesis have focused on the role of glycolysis and its major regulator HIF-1 in maintaining functional stem and progenitor cell populations 3, 4 ; however, it is not known whether mitochondrial respiration is essential for HSC function.
HSCs have low mitochondrial mass compared with more differentiated progenitors 5, 6 , reside in hypoxic niches in the bone marrow (BM) 5, 7, 8 , and are highly sensitive to oxidative stress [9] [10] [11] [12] [13] [14] . The mitochondrial respiratory chain is one of the main generators of reactive oxygen species (ROS), and accumulation of ROSinduced mitochondrial DNA (mtDNA) mutations in HSCs impairs appropriate multi-lineage differentiation 6, 15 . Furthermore, increasing mitochondrial metabolism in HSCs triggers aberrant entry into the cell cycle and ultimately stem cell exhaustion 16 . Aberrant increase in mitochondrial function can also result in loss of adult HSC quiescence 11, 16 . Deletion of the kinase LKB1 and the PTEN-like mitochondrial phosphatase (PTPMT1) in HSCs results in defective haematopoiesis with accompanying decreases of mitochondrial metabolism [17] [18] [19] [20] . Loss of AMPK in HSCs causes a similar decrease in mitochondrial metabolism as LKB1 and PTPMT1 inactivation, yet does not incur any haematopoiesis defects 20 . LKB1 and PTPMT1 are likely to affect multiple processes within HSCs, and it is not clear whether primary mitochondrial defects underlie the phenotypes observed in these knockouts. In the present study, we directly tested whether mitochondrial respiration is necessary for proliferation and maintenance of HSC and progenitor function by deleting Uqcrfs1 in fetal and adult HSCs. Uqcrfs1 encodes for the Rieske iron-sulfur protein (RISP), an essential subunit of the mitochondrial complex III (ref. 21) .
RESULTS

RISP deficiency in fetal HSCs impairs respiration and causes severe anaemia
We first investigated whether mitochondrial metabolism in HSCs was necessary for fetal development. Uqcrfs1-floxed mice were crossed to Vav-iCre mice (RISP-knockout (KO)), which constitutively express the codon-improved Cre (iCre) driven by Vav regulatory elements, resulting in HSC-specific gene deletion in mid-gestation. RISP-KO mice displayed normal Mendelian ratios at embryonic day 15.5 (E15.5) (Fig. 1a) . RISP expression was efficiently reduced in the lineage-negative (Lin − ) cells isolated from RISP-KO fetal livers (FLs) at E15.5 (Fig. 1b) . RISP-KO mice displayed paler embryos at E18.5 indicative of anaemia and died prior to completing gestation (Fig. 1c) . The FL is the main haematopoietic organ between E12.5 and E16.5, a period characterized by the expansion of the haematopoietic pool and massive production of erythrocytes 22 . RISP-KO FLs were smaller and displayed a decrease in cellularity associated with an increase in cell death ( Fig. 1c-e) . Peripheral blood analysis at E18.5 confirmed the anaemic phenotype, with severe reductions in red and white blood cells (RBCs, WBCs), haemoglobin, haematocrit and platelet numbers in the RISP-KO fetuses (Fig. 1f) . We obtained similar results from Vav-iCre + Tfam fl/fl (TFAM-KO) mice ( Supplementary Fig. 1 ). The deletion of Tfam (mitochondrial transcription factor A) results in loss of mtDNA-encoded proteins essential for mitochondrial electron transport chain function 23 . We measured biochemical parameters in Lin − FL cells. Biochemical analysis requires ample cell numbers, so we focused on this population to measure respiration. Lin − cells isolated from RISP-KO mice displayed a decrease in oxygen consumption rate ( Fig. 1g ) with an increase in extracellular acidification rate (ECAR), a measurement of glycolytic flux (Fig. 1h) . Oligomycin, an inhibitor of mitochondrial ATP synthase, increased ECAR in RISP wild-type (WT) Lin − cells, indicating that these cells can increase glycolysis in response to inhibition of mitochondrial ATP generation (Fig. 1h) . In contrast, RISP-KO Lin − cells were maximally glycolytic at baseline and did not further increase ECAR following addition of oligomycin (Fig. 1h) .
RISP-KO Lin
− cells also displayed an increase in glucose uptake consistent with the increase in glycolytic flux (Fig. 1i ).
RISP-deficient fetal HSCs are able to proliferate but have impaired differentiation
Next, we analysed HSC and multipotent progenitor (MPP) population numbers in RISP-KO mice ( Supplementary Fig. 2 ). The absolute numbers of phenotypic fetal HSCs were maintained at both E15.5 and E17.5 (Fig. 2a) . By contrast, RISP-KO FLs displayed a decrease in MPPs suggesting a defect in HSC differentiation (Fig. 2b) . RISPnull fetal HSCs displayed an increase in glucose uptake (Fig. 2c) . Unlike adult stem cells, which are mainly quiescent, fetal HSCs undergo rapid cycling. To determine whether loss of RISP affects proliferation, intraperitoneal injection of BrdU was administered to pregnant mothers carrying E15.5 embryos 6 h before analysis. RISP-KO fetal HSCs displayed an increased percentage of BrdU-positive cells, indicative of an increase in cell proliferation (Fig. 2d) . Also, annexin V staining showed a slight increase in apoptosis (Fig. 2e) . RISP deficiency resulted in diminished mitochondrial ROS (mROS), measured by MitoSOX oxidation, without changes in total ROS, as assessed by dichlorofluorescin (DCFH) oxidation (Fig. 2f) . The loss of respiration did not induce significant changes in mitochondrial membrane potential or mitochondrial mass (Fig. 2g) . Mitochondrial membrane potential can be maintained in respiratory-deficient cells by reversing the F1FoATPase to proton pump by utilizing glycolytic ATP 24 . Although RISP-KO fetal HSCs are able to proliferate, they might not be able to retain their proper stem cell functions. Indeed, we observed a decrease in a panel of genes implicated in maintenance of fetal HSC function in RISP-KO fetal HSCs (Fig. 2h) .
RISP deficiency in fetal HSCs causes depletion of myeloid progenitors
As severe anaemia was the main phenotype of the RISP-KO fetuses, we decided to investigate the underlying mechanisms by examining various myeloid progenitor (MP) populations. The total number of myeloid progenitors in the RISP-KO FL was drastically reduced (Fig. 3a) , while the frequency of myeloid progenitors was maintained (Fig. 3b) . Common myeloid progenitors (CMPs) were increased in frequency (Fig. 3b) . Interestingly, we observed a decrease in the frequency of MEPs with a concomitant increase in GMPs (Fig. 3b) . The differences in MEPs versus GMPs were reflected in the expression profile of several lineage-specific transcription factors (Fig. 3c ). GATA1 upregulation with a concomitant decrease in GATA2 is required for MEPs to differentiate into megakaryocytes and erythrocytes. PU.1 is essential for GMPs to differentiate into granulocytes and monocyte/macrophages, while C/EBPα is required for granulocyte differentiation 25 . GATA-1, but not PU.1, messenger RNA, was diminished in RISP-KO myeloid progenitors, while CEBPα and GATA2 mRNA was upregulated in sorted FL MPs (Fig. 3c) .
Next, we examined the maturation of different myeloid lineages in the RISP-KO FLs. Erythrocyte maturation was impaired in the RISP-KO shown by an increase in the frequency of proerythroblasts (R1) and a concomitant reduction in the more mature progenitors (Fig. 3d) . Absolute numbers of erythroid cells at every stage of maturation were diminished in the RISP-KO, consistent with the severe anaemia phenotype (Fig. 3d) . In contrast to the differentiation defects observed in erythroid lineages, the frequencies of immature (CD41 + /CD42 − ) and mature (CD41 + /CD42 + ) megakaryocytes, and monocytes (Mac-1 + Gr-1 − ) were increased due to loss of RISP, while granulocytes (Mac-1 + Gr-1 + ) were unchanged (Fig. 3e,f) . Again, the absolute numbers of megakaryocytes, granulocytes and monocytes were diminished due to the low numbers of total progenitors (Fig. 3e,f) . To test whether loss of RISP impairs progenitor function, we performed in vitro colony forming unit (CFU) assays. Methylcellulose cultures were scored for burst-forming unit-erythroid (BFU-E), granulocyte-erythrocytemegakaryocyte-macrophage (CFU-GEMM), and granulocyte-macrophage (CFU-GM) colonies. Cells lacking RISP gave rise to significantly fewer BFU-E and CFU-GEMM colonies compared with CFU-GM colonies (Fig. 3g) . Hypoxia, which is known to stimulate erythropoiesis, increased BFU-E colonies in RISP WT but not in RISP-KO (Fig. 3g) . Megakaryocytic colony (CFU-Mks) formation was also impaired (Fig. 3h) .
To test whether mROS levels were altered in MPs following loss of RISP, we assessed mitochondrial ROS by measuring MitoSOX fluorescence. We did not detect any difference in MitoSOX fluorescence between RISP-KO and RISP-WT MPs ( Supplementary  Fig. 3a) . Furthermore, we also did not observe any changes in mitochondrial membrane potential between RISP-KO and RISP-WT MPs ( Supplementary Fig. 3b ). To directly test whether changes in ROS affect erythrocyte differentiation, we treated pregnant mice with either pan-antioxidant NAC (to decrease ROS) or the (h) Extracellular acidification rate (ECAR) of Lin − FL cells in basal conditions and after exposure to 1 µM oligomycin A. The figure is representative of three independent experiments (WT n = 3; KO n = 3). (i) 2-NBDG uptake in Lin − FL cells. MFI, mean fluorescence intensity. Results are expressed as relative to WT (WT n = 6; KO n = 4). Data are mean ± s.e.m. * P ≤ 0.05; * * P ≤ 0.01. All P values were calculated using Student's t-test.
glutathione-depleting agent BSO (to increase ROS). The concentration of NAC utilized has previously rescued ROS-induced phenotypes observed due to the deletion of FOXOs 9 . Neither NAC nor BSO could rescue differentiation of RISP-KO erythrocytes in vivo or in vitro ( Supplementary Fig. 3c-f) . BSO was able to increase the levels of the ROS-sensitive p16 mRNA in Lin − progenitors, indicating that BSO effectively generated ROS (Supplementary Fig. 3g ). Higher concentrations of BSO did not rescue the erythrocyte maturation ( Supplementary Fig. 3h) . Thus, the impairment of erythropoiesis due to loss of RISP is likely to be independent of ROS.
Loss of RISP in fetal HSCs impairs their repopulating capacity
We evaluated the long-term repopulating capacity of RISP-WT or RISP-KO FL cells in vivo ( Supplementary Fig. 4) . RISP-deficient (Fig. 4a) . Specifically, we observed a drastic reduction in CD45.2 B cells, T cells and myeloid cells in the peripheral blood following loss of RISP (Fig. 4b) . Moreover, there was a substantial loss of RISP-deficient CD45.2 HSCs and progenitor populations in the BM 16 weeks after Cre induction with poly(I:C) (Fig. 4c) . These results were confirmed with a second independent competitive transplantation assay ( Supplementary Fig. 4d,e) . Thus, there is an intrinsic requirement for RISP in fetal HSCs to maintain haematopoiesis.
Loss of RISP in fetal HSCs causes gene expression and epigenetic changes
To investigate the cause underlying the inability of fetal HSCs to generate progenitors, we conducted RNA-seq analysis. We observed widespread gene deregulation due to loss of RISP in fetal HSCs. Specifically, 588 and 438 genes were significantly up-and downregulated in RISP-deficient HSCs (fold change ≥ 1.5, P value ≤ 0.01; Fig. 5a ). Pathway analysis revealed a significant increase in the expression of genes associated with unfolded protein response and MYC pathways, and a decrease of genes associated with the immune response, ROS and haem metabolism (Fig. 5b,c) . Recently, we demonstrated that impairment of respiration due to mtDNA loss causes hypoacetylation of certain histone marks in cancer cells 24 . Furthermore, fatty acid oxidation by mitochondria can also generate the acetyl-CoA necessary for histone acetylation 26 . We therefore conducted an unbiased mass spectrometry-based analysis of all potential histone modifications. We observed histone hypoacetylation and hypermethylation of several histone lysine modifications, as well as increased global DNA methylation as assessed by elevated 5-methylcytosine levels in RISP-KO fetal Lin − cells (Fig. 5d -f and Supplementary Table 1 ). The key histone methylation marks hyper-elevated were confirmed in a second independent experiment (Supplementary Table 2 ). Collectively, these results indicate that mitochondrial complex III is essential to maintain proper gene expression and epigenetic homeostasis in fetal HSCs and progenitors.
Loss of RISP leads to increased levels of 2-hydroxyglutarate, concomitant with a decreased NAD + /NADH ratio The increase in DNA and histone methylation following loss of RISP ( dioxygenases, including JmJC domain-containing histone lysine demethylases (KDMs) and the TET (ten-eleven translocation) family of 5-methlycytosine (5mC) hydroxylases, which are involved in oxidizing 5-methylcytosine into 5-hydroxymethylcytosine, utilize oxygen, Fe(II) and α-KG to catalyse the hydroxylation of substrates, resulting in the decarboxylation of α-KG to succinate and release of carbon dioxide 27 . The tricarboxylic acid (TCA) cycle metabolites succinate and fumarate, as well as the oncometabolite 2-hydroxyglutarate (2HG), are antagonists of α-KG, competitively inhibiting the activity of α-KG-dependent dioxygenases, including KDMs and TETs 28, 29 .
Cancer cells harbouring mutations in IDH1 and IDH2 have increased levels of D(R)-2HG, concomitant with hypermethylation of histones and DNA 27 . Cancer cells deficient in fumarate hydratase display elevated levels of fumarate associated with increased histone and DNA methylation 30, 31 . Normal cells produce L(S)-2HG from promiscuous substrate usage of α-KG by lactate dehydrogenase or malate dehydrogenase under conditions with a decreased NAD + /NADH ratio (for example, oxygen limitation 32, 33 ). L(S)-2HG is a more potent inhibitor of α-KG-dependent dioxygenases than D(R)-2HG or succinate 34 . We examined the NAD + /NADH ratio, as well as the levels of α-KG, succinate, fumarate and 2HG in WT and RISP-null FL Lin − cells. As expected, the loss of complex III function due to RISP deficiency results in a decrease in the NAD + /NADH ratio (Fig. 6a ). 2HG, α-KG, succinate and fumarate were elevated in RISP-null Lin − cells compared with WT cells (Fig. 6b) . Furthermore, the 2HG/α-KG ratio was significantly increased, while the succinate/α-KG and fumarate/αKG ratios were elevated (Fig. 6c-e) . Since L(S)-2HG is a known inhibitor of histone demethylases and TETs, these results suggest that accumulation of L(S)-2HG, fumarate and succinate in RISP-null cells results in the hypermethylation of histone and DNA observed in Fig. 5 . Glycolytic (Fig. 6f) , pentose phosphate (Fig. 6g) , and TCA cycle intermediates (Fig. 6h) , as well as the overall amino acid and nucleotide pools, were maintained in RISP-null Lin − cells ( Supplementary Fig. 5 ), indicating that the proliferating RISP-null cells are able to maintain many of the biosynthetic intermediates to support growth. Aspartate, a metabolite previously shown to be necessary for in vitro cellular proliferation and dependent on a high NAD + /NADH ratio 35, 36 was significantly diminished (Fig. 6h) .
RISP deficiency in adult HSCs impairs respiration and haematopoiesis
Adult BM HSCs are more quiescent than FL HSCs, which undergo continuous proliferation to generate blood cells in utero. We examined whether respiration was essential for adult HSCs by administering poly(I:C) to Mx1-cre mice that were crossed to Uqcrfs1-floxed mice. This generated RISP-deficient adult Lin − cells that exhibit impaired respiration, enhanced glycolysis and a decrease in the NAD + /NADH ratio ( Fig. 7a-c) . Poly (I:C) induction resulted in pancytopenia and loss of BM cellularity within 2 weeks, with subsequent lethality of animals within 3 weeks (Fig. 7d-f) . To assess the repopulating capacity of adult RISP-null HSCs, we performed a competitive reconstitution assay in which Risp fl/fl or Risp fl/fl ; Mx1-Cre BM cells (CD45.2) competed against an equal number of BM cells from a congenic (CD45.1) mouse to reconstitute the haematopoietic compartment of an irradiated recipient mouse (CD45.1). Poly (I:C) was administered after 8 weeks of engraftment, which induced a rapid decline in Cre + CD45.2 cells in the peripheral blood of mice, including T cells, B cells and myeloid cells (Fig. 7g and Supplementary Fig. 6a ). At 16 weeks post-poly(I:C), there was a substantial loss of RISP-deficient CD45.2 HSCs and progenitor populations in the BM (Supplementary Fig. 6b ). Table 2 contains the data from a second independent mass spectrometrybased epigenetic analysis using pooled Lin − FL cells from 3 WT and 3 RISP-KO animals.
These results were confirmed with a second independent competitive transplantation assay ( Supplementary Fig. 6c,d ). Thus, RISP is necessary to maintain adult HSC function in a cell-autonomous manner.
RISP maintains adult HSC quiescence
To examine the acute impact of RISP loss on HSCs and progenitor populations, we analysed the BM at 6 and 9 days after administering poly(I:C) ( Supplementary Fig. 7 ). LSK and myeloid progenitor populations were increased at day 6, but decreased by day 9 (Fig. 8a-d) .
Loss of HSC quiescence and aberrant entry into cell cycle can lead to HSC exhaustion; hence, we examined BrdU incorporation into HSCs at day 6 (Fig. 8e) . Indeed, RISP-deficient adult HSCs and progenitors displayed increased BrdU incorporation, indicating entry into cell Mx1-Cre (RISP-KO BM; n = 6 mice). Data are mean ± s.e.m. * P ≤ 0.05; * * P ≤ 0.01; NS, not significant. All P values calculated using Student's t-test.
cycle. Importantly, there was no significant decrease in viability at day 6 (Fig. 8f) . By day 9 however, despite the increase in BrdU labelling, there was significant HSC and progenitor cell death (Fig. 8g,h ). The increase in proliferation of LSK at day 6 was accompanied by elevated phospho-H2AX staining indicative of cellular stress (Fig. 8i) . Taken together these results indicate that RISP is essential for maintaining adult HSC quiescence.
DISCUSSION
Our present study identifies that completely disrupting respiration, which enhances glycolysis, diminishes fetal and adult HSC function in a cell-autonomous manner, impairing haematopoiesis, and leading to severe pancytopenia and subsequent lethality. Mitochondria, in addition to generating ATP, are biosynthetic and signalling organelles 37 . The TCA cycle generates intermediates that are essential * P < 0.05; * * P < 0.01; NS, not significant. All P values calculated using Student's t-test.
for lipid, amino acid and nucleotide synthesis, as well as for histone acetylation 24 . Fetal HSCs undergo continuous cycling and expand rapidly during development. On the basis of the critical role of mitochondria in various biosynthetic processes, the loss of respiration due to RISP depletion was predicted to decrease HSC proliferation. Surprisingly, we observed that RISP-null fetal HSCs are able to proliferate and maintain mitochondrial membrane potential; however, they lose their stem cell properties, as indicated by a decrease in stem cell genes and a loss of multi-lineage repopulation potential. HSCs give rise to multipotent progenitors that are not able to self-renew but are able to undergo a complete haematopoietic lineage differentiation. The RISP-null fetal HSCs were not able to generate sufficient numbers of multipotent progenitors indicating a defect in HSC differentiation. We and other investigators have noted that mitochondrial metabolism is essential for cellular differentiation, and our current work is consistent with these previous findings [38] [39] [40] [41] .
A potential explanation for impaired differentiation of RISPnull HSCs is the hypoacetylation due to the diminished levels of citrate generated in the mitochondria as well as the increased 2HG levels due to a decreased NAD + /NADH ratio, which cause the hypermethylation of DNA and histones. Interestingly, L(S)-2HG is oxidized in the mitochondria and converted back to α-KG by L(S)-2HG dehydrogenases (L2HGDH), a FAD-containing enzyme that is dependent on active complex III (ref. 32). Thus, loss of complex III activity both decreases NAD + /NADH and impairs L2HGDH activity to favour 2HG production. Our data are consistent with the previous finding that cancer cells harbouring mutations in the cytochrome b subunit of complex III have elevated 2HG levels 42 . L-2HG is known to drive epigenetic changes in renal cell carcinoma 43 . It is important to note that succinate and fumarate were elevated in our RISP-null cells and thus could also participate in inhibiting histone demethylases and TETs. Taken together, these data suggest that respiration controls HSC function through metabolites that regulate epigenetics, consistent with the idea that mitochondria can serve as signalling organelles.
While fetal HSCs cycle rapidly, adult HSCs are largely quiescent. Respiratory impairment in the adult HSCs caused loss of quiescence and entry into the cell cycle resulting in a depleted progenitor cell pool and lethality. Thus, respiration is not necessary for cell proliferation in either fetal or adult HSCs. This is in contrast to the observation that cancer cells with respiratory deficiency due to the loss of mtDNA display diminished tumorigenesis in vivo 44 . Additionally, the anti-diabetic drug, metformin, exerts anti-tumorigenic activity by inhibiting mitochondrial complex I, highlighting the essential requirement of the functional respiratory chain for tumour growth 45 . It is not fully understood why a functional respiratory chain is necessary for tumour cell proliferation in vivo. One model based on in vitro studies indicates that impairment of respiration decreases the NAD + /NADH ratio to limit intracellular aspartate levels required for cell proliferation 35, 36 . Moreover, a critical step in pyrimidine synthesis is the dihydroorotate dehydrogenase enzyme, which requires active complex III activity 46 . Thus, complex-III-deficient proliferating cancer cells require exogenous pyruvate to maintain the NAD + /NADH ratio for aspartate synthesis and exogenous uridine to support pyrimidine synthesis 44 . Our current findings suggest that complex-III-deficient mouse HSCs, despite decreased levels of NAD + /NADH, are able to proliferate, suggesting that they exhibit remarkable metabolic plasticity that allows them to acquire the necessary metabolites for cell proliferation in the absence of a functional respiratory chain. It is important to note that respiratory-deficient cells are able to conduct reductive TCA cycle metabolism rather than the canonical oxidative TCA metabolism to maintain metabolites levels 47 . We speculate that HSCs are not impaired in their ability to proliferate in the absence of respiration, in part because they are able to conduct reductive TCA cycle metabolism to provide adequate building blocks for proliferation. Alternatively, they may acquire metabolites from the HSC environmental niche to support proliferation.
In conclusion, we have identified three important functions of respiration in maintenance of haematopoiesis homeostasis. First, respiration is dispensable for HSC proliferation. Second, respiration is required to maintain fetal HSC differentiation into progenitors and adult HSC quiescence. Third, respiration maintains the epigenetic landscape possibly by repressing 2HG, fumarate and succinate levels in HSCs. These findings indicate that mitochondrial metabolism plays a causal role in haematopoiesis by influencing fate decisions of HSCs possibly through 2HG rather than simply fulfilling the biosynthetic and bioenergetics requirements of HSCs. Our current findings are conceptually consistent with the observations of Liu et al. 48 that mitochondrial biogenesis is necessary for erythroid progenitor cell differentiation through alterations in metabolites linked to epigenetic marks. It will be interesting to learn whether our findings extend to other stem cell models.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. L-buthionine-sulfoximine (Sigma) at 2 or 20 mM and N -acetylcysteine (Sigma) at 1 mg ml −1 were administered in drinking water to 8.5 d.p.c. (days post coitum) pregnant females until the day fetuses were extracted. Poly (I:C) (GE) was injected intraperitoneally every other day for five days at a dose of 12 mg kg −1 . All animal procedures were approved by Institutional Animal Care and Use Committee (IACUC) at Northwestern University.
Flow cytometry. Fetal livers (FLs) from 15.5-day embryos were minced with scissors in PBS containing 0.1% BSA. To obtain single-cell suspensions the tissue was triturated through a 23.5G needle and filtered through a nylon strainer (70 or 100 µm). HSC and MPP studies were performed by staining FL cells with a lineage antibody cocktail, biotin-conjugated (including CD45R/B220, CD5, Gr-1, Ter119, CD8, CD19, 7-4, Stem Cell Technologies) and posterior staining with streptavidineFluor 450 (eBioscience), CD48 (HM48-1, BD Biosciences), CD150 (TC15-12F12.2, BioLegend), Sca-1 (D7, eBioscience) and Mac-1 (M1/70, BD Biosciences). Staining with fixable viability dye eFluor 506 (eBioscience) was previously done to distinguish live from dead cells. Staining with MitoSOX or DCFH was performed at 5 µM, MitoTracker Green (MTG) at 20 nM and tetramethylrhodamine ethyl ester perchlorate (TMRE) at 5 nM (Sigma), all for 30 min at 37 • C after surface antigen staining (all from Molecular Probes). In some studies, BrdU at 100 mg kg −1 was injected intraperitoneally into pregnant females 6 h before extraction of the fetuses. FITC-BrdU staining was performed following the manufacturer's instructions (BD Biosciences). Annexin V analyses were performed with a FITC-conjugated antibody (BD Biosciences) by staining the cells in annexin V buffer (BD Biosciences) at room temperature after antigen surface staining. After that, surface antigen staining was performed as described and cells were fixed for 30 min with fixation buffer (BD Biosciences). Then, cells were incubated with pyronin Y (Sigma) at 1 µg ml −1 for 30 min at 4 • C. Lineage-negative cells were purified following the manufacturer's instructions. Lin − or HSCs were incubated with 2-NDBG (Invitrogen) at 100 µM for 1 h at 37 • C in DMEM containing SCF, IL-3 and IL-6 at 10 ng ml −1 , EPO at 3 U ml −1 and uridine at 100 µg ml −1 . In the case of the HSCs, cell death and surface antigen stainings were performed after 2-NDBG incubation.
To study lineage maturation FL cells were stained with conjugated antibodies against specific surface markers including Ter119 (BD Biosciences), CD71 (R17217, BioLegend), Mac-1 (M1/70, BD Biosciences), Gr-1 (RB6-8C5, BD Biosciences), CD41 (MWreg30, BD Biosciences) and CD42 (Xia.G5, Emfret).
Myeloid progenitors were analysed by staining with a lineage antibody cocktail, biotin-conjugated, as done for HSCs, and posterior staining with streptavidin (eBiosciences), Sca-1 (D7, eBioscience), c-kit (2B8, eBiosciences), CD34 (RAM34, eBiosciences) and FgIIIcR (2.4G2, BD Biosciences). MitoSOX and TMRE incubations were performed as described for HSCs.
BM was recovered by sequential smashing of the recovered bones using a mortar and pestle in 5 ml of HBSS + 2%FBS. The mixture was filtered through a 70 µM filter and washed 3 times with an additional 5 ml of HBSS + 2%FBS. Viability staining was performed following red blood cell lysis (eBioscience) using Live/Dead Fixable Blue Dead Cell Stain (Thermo Fisher Scientific). Surface staining was performed in PBS + 2%FBS. For lineage identification cells were stained with anti-TER119 (clone: TER-119), anti-NK1.1 (clone: PK136), anti-CD45R (clone: RA3-6B2), anti-CD4 (clone: GK1.5), anti-CD8α (clone: 53-6.7), anti-CD11b (clone: M1/70), and anti-Ly6G and Ly6C (RB6-8C5). LSK and MP were identified using anti-Sca-1 (clone: D7) and anti-CD117 (Clone 2B8). MPPs and HSCs were further classified using anti-CD150 (clone: Q38-480) and anti-CD48 (clone: HM48-1). Measurement of apoptotic cells was performed by staining cells with annexin V, Alexa Fluor 350 conjugate (Thermo Fisher) for 30 min following surface staining. Measurement of BrdU incorporation in adult mice in vivo was analysed using the BrdU Staining Kit for Flow Cytometry PerCP-eFluor 710 (eBioscience), and following the manufacturer's instructions. Mice were injected intraperitoneally with 170 mg kg −1 of BrdU (Sigma) dissolved in PBS 24 h prior to isolation of BM. Following BrdU injections, mice were kept on drinking water containing 1 mg ml −1 of BrdU until isolation.
For the BM transplantation assays, repopulation contribution was studied by staining with CD45.1 (A20, BD Biosciences), CD45.2 (104, BD Biosciences), Gr-1 (RB6-8C5, BD Biosciences), Mac-1 (M1/70, BD Biosciences), CD3 (17A2, BD Biosciences), B220 (RA3-6B2, BD Biosciences), lineage-streptavidin, Sca-1, c-kit and CD34. All flow cytometry analyses were performed in a BDLSRII or BD Fortessa analysers and data were analysed with the FlowJo software. Sorting of myeloid progenitors cells and HSCs was performed in a MoFlo FACS (Beckman-Coulter).
Protein extraction and western blot. Lineage-negative cells were purified following the manufacturer's instructions (Stem Cell Technologies). Then, cells were lysed in cell lysis buffer (Cell Signaling), resolved on 4 to 20% polyacrylamide gels (Bio-Rad) and transferred to nitrocellulose membranes. Membranes were blocked using 5% milk for 1 h and then incubated in the primary antibody overnight. Antibodies used were anti-RISP (Mitosciences; catalogue number: ab14746; used at a 1:500 dilution), anti-TFAM (a gift from G. Shadel, Yale University, USA; used at a 1:500 dilution), anti-β-actin (Sigma; catalogue number: A2066; used at 1:10,000 dilution) and anti-α-tubulin (Sigma; catalogue number: T9026; used at a 1:2,000 dilution). Membranes were washed 4 times with TBST and then incubated with secondary antibody. Secondary antibodies used were anti-mouse IgG, HRP-linked (Cell Signaling; catalogue number: 7076S; 1:10,000 dilution, used for anti-TFAM), anti-rabbit IgG, HRP-linked (Cell Signaling; catalogue number: 7074S; 1:10,000 dilution, used for anti-β-actin) and goat anti-mouse IRDye 680RD (Li-cor; catalogue number: C50721; 1:5,000 dilution; used for anti-RISP and anti-tubulin). TFAM and actin blots were then treated with ECL (Pierce) and developed using film. The RISP and tubulin blots were directly imaged using the Odyssey Fc Analyzer (Li-cor).
Blood count. Peripheral blood from 18.5-day embryos or 8-to 12-week-old adult mice was collected in EDTA-treated tubes (SARSDTED) and cell blood parameters were analysed in a HEMAVET cell blood counter machine.
Colony formation unit assays. Colony formation units for CFU-GM, BFU-E and CFU-GEMM were performed in Methocult media and CFU-Mk in MegaCultcollagen gels following the manufacturer's instructions (Stem Cell Technologies). FL cells were plated at 10 5 per well and colonies were counted 8 to 10 days after. Normoxic conditions (21% O 2 ), hypoxic conditions (1.5% O 2 ), or treatments with NAC at 500 µM or BSO at 500 µM were performed.
RNA-seq analysis. Total RNA was isolated using the RNeasy Plus Micro Kit (Qiagen) following the manufacturer's protocol. RNA-seq library was prepared using the SMARTer Stranded Total RNA-Seq Kit -Pico Input Mammalian (Takara-Clontech). Libraries were pooled and sequenced on an Illumina Nextseq500 platform using the 75 bp high-output sequencing kit. The sequencing reads were aligned to mouse Oxygen consumption and extracellular acidification rate measurements. Oxygen consumption rate and extracellular acidification rate were measured in a XF24 or XF96 extracellular flux analyser (Seahorse Bioscience). Basal mitochondrial respiration was measured by subtracting the oxygen consumption rate values after treatment with 1 µM antimycin A and 1 µM rotenone (Sigma). Coupled respiration was determined by treatment with 1 µM oligomycin A (Sigma), by the subtraction of oligomycin A values from basal respiration. Experiments were performed in Seahorse medium (DMEM containing 0.5% dialysed serum, 10 mM glucose and 2 mM glutamine, lacking bicarbonate and HEPES according to Seahorse Bioscience's instructions; the medium was supplemented with SCF, IL-3 and IL-6 at 10 ng ml −1 , EPO at 3 U ml −1 and uridine at 100 µg ml −1 ). Glycolytic flux was determined by the sensitivity of the extracellular acidification rate to 2-deoxyglucose (2DG, 40 mM). The extracted samples were analysed with LC-MS metabolomics. Metabolites were analysed for relative abundance by high-resolution accurate mass detection (HRAM). HRAM data were acquired using a QExactive Orbitrap mass spectrometer (Thermo Fisher Scientific) operated in negative ion mode coupled to an Accela pump. LC-MS in negative ion mode was achieved by using a Phenomenex Synergi Hydro-RP 100 Å (2.5 µm, 2.0 mm × 100 mm) column and by implementation of a gradient elution programme as described previously 53 . Ionization source working parameters were optimized. The heater temperature was set to 400 • C, and ion spray voltage was set to 2.75 kV. A 22 min full-scan method was used to acquire data. An m/z scan range from 80 to 1,200 was chosen and the resolution was set at 70,000. The automatic gain control (AGC) target was set at 1 × 10 6 and the maximum injection time was 500 ms. Instrument control and acquisition were carried out by Xcalibur 2.2 software (Thermo Fisher Scientific) and Tracefinder 2.1 software, respectively (Thermo Fisher Scientific). The elution gradient was carried out with a binary solvent system consisting of 3% methanol in water, 10 mM tributylamine, 15 mM acetic acid, brought to pH of 5.0 ± 0.05 using acetic acid (solvent A) and 100% methanol (solvent B) at a constant flow rate of 200 µl min −1 . The linear gradient employed was as follows: 0-2.5 min 100% A, 2.5-5 min increase from 0 to 20% B, 5-7.5 min maintain 80% A and 20% B, 7.5-13 min increase from 20 to 55% B, 13-15.5 min increase from 55 to 95% B, 15.5-18.5 min maintain 5% A and 95% B, 18.5-19 min decrease from 95 to 0% B, followed by 6 min of re-equilibration at 100% A. The column temperature was maintained at 25 • C and sample volumes of 10 µl were injected. For cellular concentrations of 2HG, lineage-negative cells were isolated as described above, and cell diameter was measured using a Cellometer Vision CBA Image Cytometer (Nexcelom). The average cell diameter was measured as 9.2 µM and the cells were assumed to be spherical and contain 70% water.
Mass spectrometry to identify histone modifications. Nuclei were isolated using gentle detergent treatment (0.3% NP-40 in NIB-250 buffer) of cells and centrifugation at 0.6g . Detergent was removed by 2× washing of obtained pellets with NIB-250, no NP-40 buffer. Histones from isolated nuclei were acidextracted and derivatized with propionic anhydride both prior to and following trypsin digestion as previously described 54 . Propionylated histone peptides were resuspended in 50 µl water with 0.1% TFA and 3 µl was injected in 3 technical replicates on a nanoLC/triple quadrupole MS that consisted of a Dionex UltiMate 3000 coupled to a Thermo Fisher Scientific TSQ Quantiva triple quadrupole mass spectrometer. Buffer A was 100% LC-MS-grade water with 0.1% formic acid and buffer B was 100% ACN. The propionylated peptides were loaded onto an inhouse packed C18 trapping column (4 cm × 150 µm; Magic AQ C18, 3 µm, 200 Å-Michrom) for 10 min at a flow rate of 2.5 µl min −1 in 0.1% TFA loading buffer. The peptides were separated by a gradient from 1 to 35% buffer B from 5 to 45 min. The analytical column was 10 cm × 75 µm PicoChip (1PCH7515-105H253-NV New Objective) and consisted of the same C18 material as the trapping column. The triple quadrupole settings were as follows: collision gas pressure of 1.5 mtorr; Q1 peak width of 0.7 (full-width at half-maximum); cycle time of 3 s; skimmer offset of 10 V; electrospray voltage of 2.5 kV. SRM mass spectrometer transitions were developed as described previously 55, 56 . Data were analysed using Skyline software (v3.5; MacCoss Lab, University of Washington) with Savitzky-Golay smoothing of peaks 57 . Automatic peak assignment and retention times were checked manually. The final results are shown as a relative percentage of the given modification in the total pool of the given peptide that was quantified. The mass spectrometry experiment measurement of all the epigenetic marks requires an abundance of cells. Thus, we pooled lineage-negative FL cells from WT and KO samples to achieve an adequate cell number for analysis.
Cytosine methylation analysis. DNA methylation was measured using the MethylFlash Methylated DNA 5-mC Quantification Kit-Colorimetric (Epigentek) following the manufacturer's instructions. In brief, DNA was isolated from purified Lin − cells using the QIAamp DNA mini kit (Qiagen). DNA concentrations were measured using the Qubit dsDNA HS Assay Kit (Thermo Fisher). CD45.2 donors and 5 × 10 5 adult BM cells from CD45.1 mice were injected retroorbitally into lethally irradiated CD45.1 recipients. At 8 weeks post-transplant mice were treated with 10 mg kg −1 of poly(I:C) (GE) every other day for five days. Levels of reconstitution in the peripheral blood were measured for 4 months using anti-CD45.1 (clone: A20), anti-CD45.2 (clone: 104), anti-CD11b (clone: M1/70), antiLy6G (RB6-8C5), anti-CD45R (clone: RA3-6B2) and anti-CD3 (clone: 17A2). Four months following poly(I:C) administration, the relative contributions to the HSC pool were analysed using the same staining protocol described above.
Statistics and reproducibility. P values were calculated by using an unpaired Student's t-test using Graphpad Prism 7 (GraphpadSoftware). Data are presented as mean ± s.e.m. unless specifically stated in the figure legend. Numbers of biological or technical replicates are stated in the figure legends. Randomization was not performed in animal experiments. The investigators were not blinded to allocation during experiments and outcome assessment. All images are representative of at least three independent experiments or mice of the same genotype. Western blots are representative of at least three independent experiments, and unprocessed original scans of blots are displayed in Supplementary Fig. 8 . No statistical method was used to predetermine sample size and experiments were not randomized. Figure S4D and S4E. Data in Figure S4D and S4E are mean ± SEM. *p ≤ 0.05; **p ≤ 0.01. All p values calculated using Student's t-test.
